COPD and Hypertension

Living with multiple conditions.

According to the American Lung Association, 24 million Americans suffer from the effects of chronic obstructive pulmonary disease (COPD), with only half officially being diagnosed with the condition. In case you didn’t know, COPD is a progressive form of lung disease that ranges from mild to severe. The disease usually features a restriction of airflow into and out of the lungs that makes breathing difficult. COPD also encompasses emphysema and chronic bronchitis.

COPD is not a disease to be taken lightly. As the third leading cause of death in the United States, ongoing research is being conducted to fully understand all aspects of the disease, including the relationship of COPD and other medical conditions. One such relationship is the effects of COPD and hypertension (high blood pressure).

The Connection between COPD and Hypertension

According to the Mayo Clinic, hypertension is defined as a common condition in which the force of the blood against a person’s artery walls is high enough that it may eventually cause severe health issues. The more blood that the heart pumps and the narrower the arteries are, the higher the blood pressure. How are COPD and hypertension connected then?

As you may have guessed, COPD takes a significant toll upon the body. Breathlessness, weight loss, sleeping and eating problems, and a depletion in energy are just some of the effects that the disease can cause for a person. COPD can also affect the workings of the heart. The nature of the disease forces the heart to work overtime.

Since the lungs are damaged, the amount of oxygen that goes to the blood is reduced. This produces high blood pressure in the blood vessels from the heart to the lungs, and makes it even more difficult for the heart to pump much-needed blood to the rest of the body. This lung disease can also cause the body to produce more red blood cells, which can make the blood thicker and harder to pump. The COPD and hypertension working together forces the person to breathe faster in order to take in more oxygen.

COPD and high blood pressure is not uncommon among patients. A doctor may test for hypertension frequently to keep track of your progress. Both of these conditions can be treated with proper medications and certain lifestyle modifications that can help improve your quality of life. If you suffer from COPD and hypertension, talk to your doctor about the best course of treatment for you.

If you or someone you know suffers from COPD and are interested in learning more about stem cell treatments, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.